Ra Medical Systems Revenue and Competitors
Estimated Revenue & Valuation
- Ra Medical Systems's estimated annual revenue is currently $6.1M per year.
- Ra Medical Systems's estimated revenue per employee is $125,500
- Ra Medical Systems's total funding is $46.5M.
Employee Data
- Ra Medical Systems has 49 Employees.
- Ra Medical Systems grew their employee count by -9% last year.
Ra Medical Systems's People
Name | Title | Email/Phone |
---|
Ra Medical Systems Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Ra Medical Systems?
Advanced Excimer Laser-Based Vascular and Dermatological Therapies We are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. We believe our products enhance patients quality of life by restoring blood-flow in arteries and clearing chronic skin conditions. We currently manufacture and market two lines of products: DABRA Catheter and Laser is cleared by the U.S. FDA as a tool for the minimally invasive endovascular treatment of vascular blockages resulting from lower extremity vascular disease, which includes peripheral artery disease (PAD), which commonly occurs in the legs. Pharos Excimer Laser Pharos is designed for use in the treatment of inflammatory skin conditions and is FDA cleared as a tool used in the treatment of psoriasis, atopic dermatitis, and leukoderma. Our goal is to become the leading medical device company marketing excimer lasers as tools for the treatment of endovascular diseases.
keywords:N/A$46.5M
Total Funding
49
Number of Employees
$6.1M
Revenue (est)
-9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ra Medical Systems News
RA MEDICAL SYSTEMS, INC. : Change in Directors or Principal Officers (form 8-K) ... Item 5.02 - Departure of Directors or Certain Officers;...
--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to...
Net revenue for 2021 was $2.6 million, which consisted of product sales of $0.9 million and service and other revenue of $1.7 million. This...
Intrance Medical Systems Raises $8 Million to Support Development of its Innovative Therapy for Advanced Parkinson’s Disease Mon, Sep 20, 2021 08:00 CET Prominent Sweden-based investor Erik Selin commits anchor investment Stockholm, Sweden and New York, NY, September 20, 2021-- Intrance Medica ...
Ra Medical Systems Announces Sale of Pharos Dermatology Business Company focused on the large and growing peripheral artery disease (PAD) market CARLSBAD, Calif. (August 16, 2021) - Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing its excimer ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.4M | 49 | -9% | N/A |
#2 | $10.8M | 50 | 35% | N/A |
#3 | $8.2M | 50 | 2% | N/A |
#4 | $9.8M | 50 | 2% | N/A |
#5 | $12.8M | 51 | 0% | N/A |